4
Changes in Ownership
Hims & Hers Health, Inc. Filed Acc 0001773751-25-000237
Chief Executive Officer sold 125,335 shares at an average $49.54 ($6,208,637)
- Chief Executive Officer acquired 125,335 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise 10b5-1 | +17,001 | $2.43 | $41,312 | 109,314 | D: show line 1 in the form |
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Sale 10b5-1 | −17,001 | $49.43 | $840,278 | 92,313 | D: show line 2 in the form |
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise 10b5-1 | +16,667 | $2.43 | $40,501 | 108,980 | D: show line 3 in the form |
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Sale 10b5-1 | −16,667 | $49.41 | $823,578 | 92,313 | D: show line 4 in the form |
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise 10b5-1 | +41,667 | $2.43 | $101,251 | 133,980 | D: show line 5 in the form |
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Sale 10b5-1 | −41,667 | $49.56 | $2,064,846 | 92,313 | D: show line 6 in the form |
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise 10b5-1 | +50,000 | $2.43 | $121,500 | 142,313 | D: show line 7 in the form |
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Sale 10b5-1 | −50,000 | $49.60 | $2,479,935 | 92,313 | D: show line 8 in the form |
| Open-market sales · 125,335 sh · avg $49.54 · $6,208,637 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise · Stock Option (right to buy) 10b5-1 | −17,001 | 68,008 | D: show line 9 in the form | |||||
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise · Stock Option (right to buy) 10b5-1 | −16,667 | 848,064 | D: show line 10 in the form | |||||
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise · Stock Option (right to buy) 10b5-1 | −41,667 | 806,397 | D: show line 11 in the form | |||||
| Dudum Andrew Chief Executive Officer | 2025-07-21 | Option exercise · Stock Option (right to buy) 10b5-1 | −50,000 | 756,397 | D: show line 12 in the form |
Loading xslF345X05/wk-form4_1753301565.xml…